Table 2.
Levels of sPD-L1 (pg/mL) in the plasma and PF of patients with different FIGO stages, grades, and Kurman–Shih types of ovarian cancer.
| Concentration of sPD-L1 (pg/mL) in Ovarian Cancer Patients |
Plasma (n = 34) | Peritoneal Fluid (n = 34) | ||||||
|---|---|---|---|---|---|---|---|---|
| Median | Minimum | Maximum | Median | Minimum | Maximum | |||
| FIGO stage | I-II (n = 11) |
69.70 | 33.15 | 131.81 | I-II (n = 11) |
75.54 | 61.25 | 207.27 |
| III-IV (n = 23) |
59.54 | 31.32 | 342,31 | III-IV (n = 23) |
100.89 | 22.91 | 231.75 | |
| Grade | G2 (n = 18) |
66.75 | 33.15 | 342.31 | G2 (n = 18) |
74.29 | 51.80 | 231.75 |
| G3 (n = 16) |
61.25 | 31.32 | 131.81 | G3 (n = 16) |
110.85 | 22.91 | 207.27 | |
| Kurman and Shih OC Type | I (n = 25) |
63.80 | 31.32 | 342.31 | I (n = 25) |
99.28 | 34.06 | 231.75 |
| II (n = 9) |
59.54 | 34.06 | 131.81 | II (n = 9) |
128.68 | 22.91 | 207.27 | |
| Control Group (n = 20) | - | 60.40 | 38.58 | 667.2 | - | - | - | |